These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14571356)

  • 41. Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.
    Nurmi EL; Spilman SL; Whelan F; Scahill LL; Aman MG; McDougle CJ; Arnold LE; Handen B; Johnson C; Sukhodolsky DG; Posey DJ; Lecavalier L; Stigler KA; Ritz L; Tierney E; Vitiello B; McCracken JT;
    Transl Psychiatry; 2013 Jun; 3(6):e274. PubMed ID: 23799528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Weight gain associated with risperidone.
    Penn JV; Martini J; Radka D
    J Clin Psychopharmacol; 1996 Jun; 16(3):259-60. PubMed ID: 8784664
    [No Abstract]   [Full Text] [Related]  

  • 43. Risperidone-induced hepatotoxicity.
    Benazzi F
    Pharmacopsychiatry; 1998 Nov; 31(6):241. PubMed ID: 9930641
    [No Abstract]   [Full Text] [Related]  

  • 44. Risperidone, weight gain, and bulimia nervosa.
    Crockford DN; Fisher G; Barker P
    Can J Psychiatry; 1997 Apr; 42(3):326-7. PubMed ID: 9114956
    [No Abstract]   [Full Text] [Related]  

  • 45. Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents.
    Calarge CA; Ellingrod VL; Zimmerman B; Acion L; Sivitz WI; Schlechte JA
    Psychiatr Genet; 2009 Dec; 19(6):320-7. PubMed ID: 19873684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children.
    Bahr SM; Tyler BC; Wooldridge N; Butcher BD; Burns TL; Teesch LM; Oltman CL; Azcarate-Peril MA; Kirby JR; Calarge CA
    Transl Psychiatry; 2015 Oct; 5(10):e652. PubMed ID: 26440540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risperidone-induced polydipsia and polyphagia associated with galactorrhea, abdominal pain, and rapid weight gain in an adolescent Hispanic female.
    Afzal KI; Briones DF; DeVargas C
    CNS Spectr; 2007 Nov; 12(11):818-20. PubMed ID: 17984854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risperidone induced weight gain leading to benign intracranial hypertension.
    Ahmed H; Ali H
    BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antipsychotic agents and weight gain].
    Raaska K
    Duodecim; 2002; 118(2):157-62. PubMed ID: 12229110
    [No Abstract]   [Full Text] [Related]  

  • 50. Missed diagnosis of tardive dystonia in an adolescent girl treated with risperidone.
    Pringsheim T
    J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):191-4. PubMed ID: 21486170
    [No Abstract]   [Full Text] [Related]  

  • 51. Massive, previously undetected cancer metastasis revealed by application of a depot antipsychotic: a case report.
    Haeckert J; Bunse T; Wirth S; Hamerle M; Falkai P; Hasan A
    J Clin Psychiatry; 2014 Jul; 75(7):e705-6. PubMed ID: 25093486
    [No Abstract]   [Full Text] [Related]  

  • 52. Risperidone-induced cholestatic hepatitis.
    Krebs S; Dormann H; Muth-Selbach U; Hahn EG; Brune K; Schneider HT
    Eur J Gastroenterol Hepatol; 2001 Jan; 13(1):67-9. PubMed ID: 11204814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Body weight gain after administration of antipsychotic drugs.
    Baptista T; Lacruz A; De Mendoza D; Mendoza JM; Silvera R; Angeles F; Mendoza MT; Hernandez L
    Pharmacopsychiatry; 2002 Jan; 35(1):36. PubMed ID: 11819161
    [No Abstract]   [Full Text] [Related]  

  • 54. Weight Gain During Antipsychotic Treatment in Children, Adolescents, and Adults: A Disproportionality Analysis in the Global Pharmacovigilance Database, Vigibase
    Kaguelidou F; Valtuille Z; Durrieu G; Delorme R; Peyre H; Treluyer JM; Montastruc F; Chouchana L
    Drug Saf; 2023 Jan; 46(1):77-85. PubMed ID: 36459374
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is liver function monitoring warranted during risperidone treatment?
    Landau J; Martin A
    J Am Acad Child Adolesc Psychiatry; 1998 Oct; 37(10):1007-8. PubMed ID: 9785708
    [No Abstract]   [Full Text] [Related]  

  • 56. Hyperleptinemia contributes to antipsychotic drug-associated obesity and metabolic disorders.
    Zhao S; Lin Q; Xiong W; Li L; Straub L; Zhang D; Zapata R; Zhu Q; Sun XN; Zhang Z; Funcke JB; Li C; Chen S; Zhu Y; Jiang N; Li G; Xu Z; Wyler SC; Wang MY; Bai J; Han X; Kusminski CM; Zhang N; An Z; Elmquist JK; Osborn O; Liu C; Scherer PE
    Sci Transl Med; 2023 Nov; 15(723):eade8460. PubMed ID: 37992151
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arterial hypertension and posterior reversible cerebral edema syndrome induced by risperidone.
    Milani GP; Bianchetti MG; Mazzoni MB; Triulzi F; Mauri MC; Agostoni C; Fossali EF
    Pediatrics; 2014 Mar; 133(3):e771-4. PubMed ID: 24567018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treating acquired haemophilia: an ethical conundrum.
    Starr JM
    Age Ageing; 2001 Jan; 30(1):87-8. PubMed ID: 11322683
    [No Abstract]   [Full Text] [Related]  

  • 59. Metformin-Induced Type 1 Hypersensitivity in a Child with Antipsychotic-Induced Weight Gain.
    Mennella C; Dickstein DP
    J Child Adolesc Psychopharmacol; 2017 Feb; 27(1):106-107. PubMed ID: 27548055
    [No Abstract]   [Full Text] [Related]  

  • 60. Severe extrapyramidal reaction due to risperidone in a case of neurofibromatosis.
    De León OA; Jobe TH; Furmaga KM; Gaviria M
    J Clin Psychiatry; 1997 Jul; 58(7):323. PubMed ID: 9269254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.